Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06908889 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Characterization of Bacterial and Mycosis Skin Flora in Seborrheic Macular Hypopigmentation - Microbiome

Study acronym: Microbiome_SHM
StatusActive, Not Recruiting
PhaseNot applicable
Started2025-06-25
View on ClinicalTrials.gov ↗

Amendment history

2026-09-30
notable
Enrollment closed, study ongoing
Primary completion confirmed: April 2026 (last estimated January 2026)
Completion pushed: 2026-06-25 → 2026-12-25
2025-06-27
notable
Not Yet Recruiting→Recruiting Study Status, Oversight, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Primary completion date2025-12-03→2026-01-25
Completion date2026-05-03→2026-06-25
Start dateestimated 2025-05-03→confirmed 2025-06-25
Study sitesdetails revised at 3 of 3 sites
2025-04-03
minor
Study Status, Study Design v1
Re-verified, no change to tracked fields
2025-04-01
minor
Original filing
Hypopigmented skin changes are commonly encountered by dermatologists. A new dermatological entity was identified as scattered, hypopigmented oval-shaped macules and patches distributed mostly in seborrheic area of the face and of the trunk in dark skinned individuals. This patterned presentation of hypopigmentation was first described in the literature under the name of hypochromic vitiligo or vitiligo minor. Nerveless, histopathological patient's specimens analyzed by Krueger et al. clearly highlight that there is no tangible causal correlation with a diagnosis of vitiligo. They propose to rename this entity to Seborrheic Macular Hypopigmentation (SMH). The etiopathology of this dermatosis is still unknown preventing to propose any satisfactory treatment for this disfiguring affection.The objective of this study is to analyze the bacterial and fungal skin microbiome on hypochromic lesions of SMH compared to the surrounding non-lesional skin of the same patients and to healthy volunteers
Trial Details
NCT Number NCT06908889
Lead Sponsor Centre Hospitalier Universitaire de Nice
Conditions Hypopigmentation
Enrollment 20 participants
Start Date 2025-06-25
Primary Completion 2026-04-16 (estimated)
Study Completion 2026-12-25 (estimated)
Updated on ClinicalTrials.gov 2026-09-29